ABOUT THIS PODCAST
Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes.
SHOW NOTES
- ASHP Statement on the Pharmacist’s Role in Substance Use Disorder Prevention, Treatment, and Recovery
- Clinical Pharmacist Practitioners Prescribing of Buprenorphine for Opioid Use Disorder
SPEAKERS
- Monica Mehta, PharmD, MPH
Director, Policy Planning, ASHP - Terri Jorgenson, RPh, BCPS
National Program Manager, Clinical Practice Integration and Model Advancement, Department of Veterans Affairs - Jeffrey Bratberg, PharmD, FAPhA
Clinical Professor, University of Rhode Island College of Pharmacy - Tran H. Tran, PharmD, BCPS
Medical Science Liaison, Central Region at Braeburn Pharmaceuticals
